Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018

Go back to Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Delayed: 155.75 +0.11 (0.07%)
Previous Close $155.64    52 Week High $58.46 
Open $153.99    52 Week Low $31.25 
Day High $156.82    P/E N/A 
Day Low $151.77    EPS $-0.69 
Volume 365,954